Follow The Filings

AVY Avery Dennison

Materials, filed as AVERY DENNISON ORD (EQUITY), Equity Among managers we track Quote on Google Finance, opens in a new tab

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

Insider trades

Open-market buys and sales by AVY's executives, directors and 10% owners in the last 12 months, from their Form 4s

All AVY insider trades
  • None no insider bought on the open market
  • $1.2M sold by 2 insiders outside a trading plan
  • $20M sold by 1 insider under 10b5-1 plans
  1. Nicholas Colisto SVP & CIO
    Sale
    $663K 3,886 shares at $170.68 35% of stake
    Traded Sep 15 Filed Sep 16
    ↗
  2. Ignacio J Walker SVP and Chief Legal Officer
    Sale
    $299K 1,742 shares at $171.61 19% of stake
    Traded Aug 4 Filed Aug 5
    ↗
  3. Mitchell R Butier Director
    Planned sale
    $5.7M 33,000 shares at $172.95 14% of stake
    Traded Mar 11–12 Filed Mar 13
    ↗
  4. Mitchell R Butier Director
    Planned sale
    $7M 40,000 shares at $175.81 15% of stake
    Traded Mar 9–10 Filed Mar 11
    ↗
  5. Mitchell R Butier Director
    Planned sale
    $7.3M 40,000 shares at $181.92 13% of stake
    Traded Mar 5–6 Filed Mar 9
    ↗
  6. Ignacio J Walker SVP and Chief Legal Officer
    Sale
    $223K 1,156 shares at $192.95 13% of stake
    Traded Feb 6 Filed Feb 9
    ↗

Also filed in the last 12 months, not counted as buying or selling: 53 option exercises, 46 share withholdings for taxes, and 2 other transactions.

Congress

2 members of Congress traded AVY in the last three years: 0 buys and 3 sales.

All Congress trades
  1. Robert P. Bresnahan, Jr. R-PA-8 Sell $1K–$15K Apr 8, 2025 filed May 8, 2025
  2. Robert P. Bresnahan, Jr. R-PA-8 Sell $1K–$15K Feb 25, 2025 filed Mar 27, 2025
  3. John James R-MI-10 Sell $1K–$15K Sep 4, 2024 filed Sep 6, 2024

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 8.01 Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated 2 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $8.36B $8.76B $8.86B
Gross profit $2.28B $2.53B $2.55B
Gross margin * 27.2% 28.9% 28.8%
Net income $503M $704.9M $688M
Net margin * 6.0% 8.1% 7.8%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $2.8B $3.08B $2.99B
Total non-current assets * $5.41B $5.33B $5.81B
Total assets $8.21B $8.4B $8.8B
Total current liabilities $2.7B $2.86B $2.65B
Total equity $2.13B $2.31B $2.24B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $826M $938.8M $881.4M
Cash from investing -$459M -$243.1M -$596M
Cash from financing -$317.2M -$576.1M -$414.9M
Net change in cash $47.8M $114.1M -$126.3M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.